Regarding medications, almost all participants from the North/Northeast (97%) with anemia had a prescription of erythropoietin for more than 50% of the assessed time, a number markedly higher than the 53% of the South, 77% of the Southeast, and 71% of the Midwest. The gene discussed is EPO; the disease is anemia.